Bausch Health Companies Inc. (TSX:BHC)

Canada flag Canada · Delayed Price · Currency is CAD
6.30
-0.05 (-0.79%)
May 28, 2025, 4:00 PM EDT
-25.97%
Market Cap 2.33B
Revenue (ttm) 13.99B
Net Income (ttm) -57.49M
Shares Out n/a
EPS (ttm) -0.16
PE Ratio n/a
Forward PE 1.14
Dividend n/a
Ex-Dividend Date n/a
Volume 407,467
Average Volume 371,959
Open 6.37
Previous Close 6.35
Day's Range 6.23 - 6.37
52-Week Range 5.45 - 13.74
Beta 0.34
RSI 39.02
Earnings Date Apr 30, 2025

About Bausch Health Companies

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products. The Intern... [Read more]

Sector Healthcare
CEO Thomas Appio
Employees 20,700
Stock Exchange Toronto Stock Exchange
Ticker Symbol BHC
Full Company Profile

Financial Performance

In 2024, Bausch Health Companies's revenue was $9.63 billion, an increase of 9.91% compared to the previous year's $8.76 billion. Losses were -$46.00 million, -92.23% less than in 2023.

Financial numbers in USD Financial Statements

News

Facial Injectable Market Forecasts Report 2025-2030, Competitive Analysis of Key Players - Allergan, Bausch Health, Bloomage Biotechnology, and Galderma

The facial injectable market is poised for significant growth, with a rise from US$18.310 billion in 2025 to US$32.083 billion by 2030, driven by an 11.87% CAGR. Increasing emphasis on physical appear...

7 days ago - GlobeNewsWire

Bausch + Lomb Launches New LUMIFY® Preservative Free Redness Reliever Eye Drops in the United States

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launc...

7 days ago - Business Wire

Bausch Health Announces 2025 Annual Meeting of Shareholder Results

LAVAL, QC / ACCESS Newswire / May 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced the election of the 10 directors nominated at its 2025 annual meeting of shareholders ("An...

14 days ago - Accesswire

Bausch + Lomb Launches Zenlens® CHROMA HOA™ in the United States

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launc...

14 days ago - Business Wire

Bill Ackman Took A $4 Billion Hit But Says 'Making Progress Each Day' Was Key To Recovering From The Valeant Disaster

Billionaire investor Bill Ackman opened up about the most painful chapter of his career—the collapse of his $4 billion investment in Valeant Pharmaceuticals . In a candid interview, he explained how t...

19 days ago - Benzinga

Bausch + Lomb Receives European CE Mark Approval for Preloaded LuxLife® Full Range of Vision Intraocular Lens

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced CE Mark approv...

21 days ago - Business Wire

Xifaxan(R) (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization

New analysis suggests efficacy of Xifaxan to mitigate OHE rehospitalizations irrespective of treatment history LAVAL, QC / ACCESS Newswire / May 6, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:B...

22 days ago - Accesswire

Bausch Health Companies Inc. (BHC) Q1 2025 Earnings Call Transcript

Bausch Health Companies Inc. (NYSE:BHC) Q1 2025 Earnings Conference Call April 30, 2025 5:00 PM ETCompany ParticipantsGaren Sarafian - IRThomas Appio -...

27 days ago - Seeking Alpha

Bausch Health Companies Inc. 2025 Q1 - Results - Earnings Call Presentation

The following slide deck was published by Bausch Health Companies Inc.

27 days ago - Seeking Alpha

Bausch Health Announces First Quarter 2025 Results

First Quarter Consolidated Revenues of $2.26 billion, up 5% on a Reported basis and 6% on an Organic (non-GAAP) 1 basis over the prior year period GAAP Net Loss Attributable to Bausch Health Companies...

4 weeks ago - Accesswire

Bausch Health Announces Health Canada Clearance of Solta Medical's Thermage(R) FLX System

A Long-Awaited Advancement in Non-Invasive Radiofrequency Skin Tightening Is Now Approved for the Canadian Market LAVAL, QC / ACCESS Newswire / April 29, 2025 / Bausch Health Companies Inc. (NYSE:BHC)...

4 weeks ago - Accesswire

Notable healthcare headlines for the week: Merck, Roche and Bausch Health in focus

Wall Street powered to its second-best weekly advance of 2025 on Friday, with the benchmark S&P 500 (SP500) jumping nearly 5%. For the week, the S&P advanced +4

4 weeks ago - Seeking Alpha

Bausch Health Learns Icahn Has 34% Economic Interest in Shares

Activist investor Carl Icahn has tightened his hold on pharmaceutical company Bausch Health.

5 weeks ago - WSJ

Bausch Health says Carl Icahn has exposure to about 34% of company's shares

Billionaire Carl Icahn has a total economic exposure of about 34% to Bausch Health's common shares, the healthcare firm said in a filing on Tuesday.

5 weeks ago - Reuters

Bausch Health Announces Filing of Supplement to Proxy Statement

Supplement In Response to Company Learning that Carl Icahn and Affiliates Have Cash-Settled Equity Swaps for Approximately 90 Million of Its Common Shares LAVAL, QC / ACCESS Newswire / April 22, 2025 ...

5 weeks ago - Accesswire

Bausch + Lomb Reports More Than 100 Million Units of Contacts Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its exclusive ...

5 weeks ago - Business Wire

U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, and Teva, and Against Norwich

LAVAL, QC / ACCESS Newswire / April 17, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health"), and its gastroenterology business Salix Pharmaceuticals, Inc., today...

5 weeks ago - Accesswire

Bausch Health Companies Inc (BHC) Adopts Shareholder Rights Plan | BHC stock news

Bausch Health Companies Inc (BHC) Adopts Shareholder Rights Plan | BHC stock news

6 weeks ago - GuruFocus

Bausch Health Announces Adoption of Shareholder Rights Plan

LAVAL, QC / ACCESS Newswire / April 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health") announces today that its board of directors (the "Board") has approve...

6 weeks ago - Accesswire

Bausch Health Companies Inc (BHC) Launches 2025 ASPIRE HIGHER Scholarship Program | BHC stock news

Bausch Health Companies Inc (BHC) Launches 2025 ASPIRE HIGHER Scholarship Program | BHC stock news

6 weeks ago - GuruFocus

Bausch Health Announces Ortho Dermatologics 2025 ASPIRE HIGHER Scholarship Program

Bausch Health is offering scholarships to six students impacted by dermatologic conditions, with application submissions open through June 11, 2025 LAVAL, QC / ACCESS Newswire / April 10, 2025 / Bausc...

6 weeks ago - Accesswire